Friday, January 18, 2008

The symptoms & treatment of TENS

The symptoms of TENS

Both Toxic Epidermal Necrolysis and SJS can start with non-specific symptoms such as cough, aching, headaches, and feverishness. This can be followed by more specific symptoms such as a red rash across the face and the trunk of the body, which can continue to spread to other parts of the body. The rash can form into blisters, and these blisters can form in areas such as the eyes, mouth and vaginal areas. The mucous membranes can become inflamed, and with Toxic Epidermal Necrolysis layers of the skin can also come away with ease and often the skin peels away in sheets. The hair and nails can also come away in some cases, and sufferers can become cold and feverish.

The most common cause of death in the case of TENS is infection, which can be contracted through the exposed areas where the skin has come away from the flesh. The skin on patients that have this disease can resemble badly burned skin because of the extent to which it can flay, and exposed areas can seep fluids and become quickly infected.

Treatment for TENS

Those suffering from TENS are treated in hospital, and if the cause of the problem is drug related then the drugs are stopped immediately. Surviving patients are treated intravenously to replace any lost fluids, and the skin is left to re-grow on its own. However, the chances of survival can vary dramatically depending on the level of damage and the degree of infection incurred by the patient.

It is strongly advised that those taking drugs that could result in these TENS are vigilant and can identify the danger signs associated with this skin disease. Toxic Epidermal Necrolysis is potentially deadly, and the earlier the symptoms are recognised the faster treatment can be initiated.

People that have been affected by any drug in this way – or the families of those that have passed away because of problems and diseases such as TENS – may be eligible to claim compensation, and are advised to seek legal assistance as soon as possible following diagnosis of the disease

No comments: